Literature DB >> 16780886

The role of mental function in the pathogenesis of freezing of gait in Parkinson's disease.

Nir Giladi1, Jeffrey M Hausdorff.   

Abstract

Freezing of gait (FOG) is a disabling episodic gait disturbance that is common among patients with Parkinsonism. FOG typically lasts a few seconds and is associated with a unique sensation: the patient feels that his feet are glued to the ground, causing him to remain in place despite making a concerted effort to overcome the motor block and move forward. Traditionally, FOG has been viewed as a motor symptom of advanced Parkinson's disease. Here we describe evidence which demonstrates that mental conditions also likely play an important role in the pathogenesis of FOG. Stress, anxiety, depression and cognitively challenging situations are associated with FOG, and may set the stage for and increase the likelihood that FOG occurs. A conceptual model that explains how mental conditions may modulate FOG is developed.

Entities:  

Mesh:

Year:  2006        PMID: 16780886     DOI: 10.1016/j.jns.2006.05.015

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  62 in total

1.  Heart rate changes during freezing of gait in patients with Parkinson's disease.

Authors:  Inbal Maidan; Meir Plotnik; Anat Mirelman; Aner Weiss; Nir Giladi; Jeffrey M Hausdorff
Journal:  Mov Disord       Date:  2010-10-30       Impact factor: 10.338

2.  Generalized motor inhibitory deficit in Parkinson's disease patients who freeze.

Authors:  Patrick G Bissett; Gordon D Logan; Nelleke C van Wouwe; Christopher M Tolleson; Fenna T Phibbs; Daniel O Claassen; Scott A Wylie
Journal:  J Neural Transm (Vienna)       Date:  2015-09-09       Impact factor: 3.575

3.  Does freezing in Parkinson's disease change limb coordination? A kinematic analysis.

Authors:  Nieuwboer Alice; Chavret Fabienne; Willems Anne-Marie; Desloovere Kaat
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

4.  Regional gray matter atrophy in patients with Parkinson disease and freezing of gait.

Authors:  A Tessitore; M Amboni; G Cirillo; D Corbo; M Picillo; A Russo; C Vitale; G Santangelo; R Erro; M Cirillo; F Esposito; P Barone; G Tedeschi
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-26       Impact factor: 3.825

5.  Short rapid steps to provoke freezing of gait in Parkinson's disease.

Authors:  Jorik Nonnekes; Arno M Janssen; Senja H G Mensink; Lars B Oude Nijhuis; Bastiaan R Bloem; Anke H Snijders
Journal:  J Neurol       Date:  2014-06-24       Impact factor: 4.849

6.  Changes in oxygenated hemoglobin link freezing of gait to frontal activation in patients with Parkinson disease: an fNIRS study of transient motor-cognitive failures.

Authors:  Inbal Maidan; Hagar Bernad-Elazari; Eran Gazit; Nir Giladi; Jeffery M Hausdorff; Anat Mirelman
Journal:  J Neurol       Date:  2015-01-31       Impact factor: 4.849

7.  New evidence for gait abnormalities among Parkinson's disease patients who suffer from freezing of gait: insights using a body-fixed sensor worn for 3 days.

Authors:  Aner Weiss; Talia Herman; Nir Giladi; Jeffrey M Hausdorff
Journal:  J Neural Transm (Vienna)       Date:  2014-07-29       Impact factor: 3.575

8.  Freezing of gait in older adults with high level gait disorders: association with impaired executive function.

Authors:  N Giladi; V Huber-Mahlin; T Herman; J M Hausdorff
Journal:  J Neural Transm (Vienna)       Date:  2007-06-18       Impact factor: 3.575

Review 9.  Cognitive aspects of freezing of gait in Parkinson's disease: a challenge for rehabilitation.

Authors:  Elke Heremans; A Nieuwboer; J Spildooren; J Vandenbossche; N Deroost; E Soetens; E Kerckhofs; S Vercruysse
Journal:  J Neural Transm (Vienna)       Date:  2013-01-18       Impact factor: 3.575

Review 10.  Postural instability in patients with Parkinson's disease. Epidemiology, pathophysiology and management.

Authors:  Samuel D Kim; Natalie E Allen; Colleen G Canning; Victor S C Fung
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.